Archive for the ‘Viruses’ Category

New Federally Funded Study Which Threw Out 75% of Cases & Didn’t Stratify for Gender Admits Covid Shot Health Risk For Children

https://jamanetwork.com/journals/jamapediatrics/fullarticle/2805184

May 22, 2023

Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years

Mao Hu, BS1; Hui Lee Wong, PhD, MSc2; Yuhui Feng, MS1; et alPatricia C. Lloyd, PhD, ScM2; Elizabeth R. Smith, BS1; Kandace L. Amend, PhD3; Annemarie Kline, MS5; Daniel C. Beachler, PhD, MPH4; Joann F. Gruber, PhD2; Mahasweta Mitra, MPH1; John D. Seeger, DrPH, PharmD3; Charlalynn Harris, MPH, PhD5; Alex Secora, PhD6; Joyce Obidi, PhD2; Jing Wang, BA1; Jennifer Song, MA, MURP3; Cheryl N. McMahill-Walraven, PhD5; Christian Reich, MD, PhD6; Rowan McEvoy, BS1;  Rose Do, MD1;  Yoganand Chillarige, MPA1;  Robin Clifford, MS, BS3; Danielle D. Cooper, MPH5; Azadeh Shoaibi, PhD, MHS2; Richard Forshee, PhD2; Steven A. Anderson, PhD, MPP2
Author Affiliations Article Information
JAMA Pediatr. Published online May 22, 2023. doi:10.1001/jamapediatrics.2023.1440
COVID-19 Resource Center
Abstract

Importance  Active monitoring of health outcomes after COVID-19 vaccination offers early detection of rare outcomes that may not be identified in prelicensure trials.

Objective  To conduct near–real-time monitoring of health outcomes following BNT162b2 COVID-19 vaccination in the US pediatric population aged 5 to 17 years.

Design, Setting, and Participants  This population-based study was conducted under a public health surveillance mandate from the US Food and Drug Administration. Participants aged 5 to 17 years were included if they received BNT162b2 COVID-19 vaccination through mid 2022 and had continuous enrollment in a medical health insurance plan from the start of an outcome-specific clean window until the COVID-19 vaccination. Surveillance of 20 prespecified health outcomes was conducted in near real time within a cohort of vaccinated individuals from the earliest Emergency Use Authorization date for the BNT162b2 vaccination (December 11, 2020) and was expanded as more pediatric age groups received authorization through May and June 2022. All 20 health outcomes were monitored descriptively, 13 of which additionally underwent sequential testing. For these 13 health outcomes, the increased risk of each outcome after vaccination was compared with a historical baseline with adjustments for repeated looks at the data as well as a claims processing delay. A sequential testing approach was used, which declared a safety signal when the log likelihood ratio comparing the observed rate ratio against the null hypothesis exceeded a critical value.

Exposure  Exposure was defined as receipt of a BNT162b2 COVID-19 vaccine dose. The primary analysis assessed primary series doses together (dose 1 + dose 2), and dose-specific secondary analyses were conducted. Follow-up time was censored for death, disenrollment, end of the outcome-specific risk window, end of the study period, or a receipt of a subsequent vaccine dose.

Main Outcomes  Twenty prespecified health outcomes: 13 were assessed using sequential testing and 7 were monitored descriptively because of a lack of historical comparator data.

Results  This study included 3 017 352 enrollees aged 5 to 17 years. Of the enrollees across all 3 databases, 1 510 817 (50.1%) were males, 1 506 499 (49.9%) were females, and 2 867 436 (95.0%) lived in an urban area. In the primary sequential analyses, a safety signal was observed only for myocarditis or pericarditis after primary series vaccination with BNT162b2 in the age group 12 to 17 years across all 3 databases. No safety signals were observed for the 12 other outcomes assessed using sequential testing.

Conclusions and Relevance  Among 20 health outcomes that were monitored in near real time, a safety signal was identified for only myocarditis or pericarditis. Consistent with other published reports, these results provide additional evidence that COVID-19 vaccines are safe in children.

_______________

**Comment**

Please notice the strategic use of the word only.  Sorry but myocarditis and pericarditis are not small matters.  To suggest that it is normal for young people to go through life with a heart condition is truly abominable and demonstrates perfectly tyranny of the past three years. Dr. McCullough writes that myocarditis is not recovered in 80% at 6 months after the gene therapy injections.

________________

https://popularrationalism.substack.com/p/jama-study-by-us-fda-reports

JAMA STUDY BY US FDA REPORTS RECORD-BREAKING 50-FOLD INCREASED RISK OF MYOCARDITIS, 10-FOLD INCREASED RISK IN 5-11, SAYS IT “ONLY” FINDS MYOCARDITIS AND PERICARDITIS IN CHILDREN AGED 15 TO 17 YEARS

They did not stratify the results by gender and dropped 75% of the records due to lack of medical records. RRs reported? 5.50, 3.95, 10.19, 3.47, 10.26, 22.44, 8.72, 3.49, 18.65, 4.98, 10.29, 50.01.

JAMES LYONS-WEILER
MAY 26, 2023

Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years | Pediatrics | JAMA Pediatrics | JAMA Network

One of the authors of the study is from the US Food and Drug Administration.

Dropping the 75% without medical records no doubt reduced the statistical power, the same trick used by the infamous Destefano et al study (2004) to make the association between on-time MMR vaccines and autism go away after rigorous p-hacking.

These are kids. Please retweet or share somewhere, wherever you hang out online.

(See link for article)

For more:

Many are trying to normalize heart conditions, particularly in children and babies and the timing is suspicious.

Category:

Activism, Heart Issues, vaccines, Viruses

Maine’s First Powassan 2023 Death

https://www.dailymail.co.uk/health/article-12129323/Aggressive-tick-borne-virus-death-Maine-expected-common-climate-warms

Tick-borne disease that kills up to 15% of sufferers just claimed its first life in the US this year — and experts warn the virus is becoming more common due to CLIMATE CHANGE

By CASSIDY MORRISON SENIOR HEALTH REPORTER FOR DAILYMAIL.COM

UPDATED: 

Health officials in Maine reported the first death this year of an untreatable tick-borne illness, putting Americans on alert as outdoor warm-weather activities kick off.

Robert J. Weymouth, a 58-year-old from Topsham, Maine passed away due to complications from the Powassan virus, which caused severe neurological problems, according to the Maine Center for Disease Control and Prevention.

The illness is extremely rare with about 25 cases reported each year since 2015, but it is also untreatable and can lead to severe health problems including infection of the brain, called encephalitis, or of the membranes around the brain and spinal cord, known as meningitis.

Many people who become infected with the virus do not develop symptoms, but those that do typically notice them up to a month after being bitten by an infected tick, which could include flu-like symptoms, seizures, brain swelling, and, in up to 15 percent of cases, death.

Weymouth’s death marks the third Powassan death in Maine since 2015, and, as winters become warmer and shorter, the world becomes a more hospitable place for disease-causing ticks.  (See link for article)

_________________

A few points:

  • Powassan, like any other virus IS TREATABLE; however, doctors are not catching it early enough because they are uneducated about tick-borne illness. It’s highly politicalized and has polarized the medical community.  Doctors are too afraid to diagnose and treat it due to this and are either ignorant or acting ignorantly out of self-preservation.  Either way, it’s not a good scenario & patients lose.
  • Powassan is rarely diagnosed because most who contract it are asymptomatic – similarly to many other viruses – but also because testing is not available through clinical or commercial laboratories, but only through the Health Department. Further limiting diagnosis:
    • Patients should be hospitalized with meningitis or encephalitis
    • Have a presumed infectious cause of illness
    • Be negative or concurrently tested for more common causes of meningitis and encephalitis such as West Nile virus, Lyme disease, herpes and varicella.
  • The patient’s wife was “frustrated at how little the doctors around her husband seemed to know about the illness. He was in the hospital for weeks before the medical team determined he had the virus.”  And, BINGO!  This, right here is the problem not that it is untreatable.  Please begin to pick up the continued use of language blaming peripheral things instead of addressing the root of the problem.
  • And speaking of the continued emphasis on peripheral things rather than root issues, the title makes sure to bluster about “climate change,” a contentious but popular topic that many experts are flat-out denying and an independent researcher has stated has ZERO to do with tick and tick-borne disease proliferation.  Very little is discussed about the tweaking of ticks in labs and then dropping them out of airplanes.  Very little is discussed about the continued denial of chronically infected patients, the research showing it, and the juggernaut on faulty testing – which our government owns the patents on.  As you can see, ‘climate change’ is a wonderful diversion from these issues that would put the government in the spot-light.
  • Please note that Wisconsin is a hot-spot for Powassan.  Please read this article on how Powassan IS NOT RARE.
  • Coppe Labs, a specialized CLIA-certified lab, right in Waukesha, Wisconsin tests for Powassan, West Nile, Anaplasma, Babesia, Human Herpes Viruses 6 & 7, COVID, and Lyme disease.

For more on Powassan:

Category:

Testing, Ticks, Viruses

The Great Awakening Trailer

By the creators of Plandemic

https://rumble.com/v2of57c-the-great-awakening-trailer.html  Trailer Here (Approx. 3 Min)

The livestream event is FREE and hosted by The HighWire. Spread the word with hashtag #TheGreatAwakeningFilm

It all happens on Saturday, June 3rd, at 6pm CT (UTC-5:00)!

Sign up today at PlandemicSeries.com

Go here to see more short videos on many topics in the Plandemic Series

Category:

Activism, vaccines, Viruses

Study: How the COVID Pandemic Response Harmed Society

**NOTE**

This paper does not even include C19 injection policies or harms and deaths.

https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4447806

How Did the COVID Pandemic Response Harm Society? A Global Evaluation and State of Knowledge Review (2020-21)

Posted: 22 May 2023

Kevin Bardosh

University of Washington; University of Edinburgh – Edinburgh Medical School

Date Written: May 14, 2023

Abstract

Early in the Covid pandemic concerns were raised that lockdown and other non-pharmaceutical interventions would cause significant multidimensional harm to society. This paper comprehensively evaluates the global state of knowledge on these adverse social impacts, with an emphasis on their type and magnitude during 2020 and 2021. A harm framework was developed spanning 10 categories: health, economy, income, food security, education, lifestyle, intimate relationships, community, environment and governance. The analysis synthesizes 600 publications with a focus on meta-analyses, systematic reviews, global reports and multi-country studies. This cumulative academic research shows that the collateral damage of the pandemic response was substantial, wide-ranging and will leave behind a legacy of harm for hundreds of millions of people in the years ahead. Many original predictions are broadly supported by the research data including: a rise in non-Covid excess mortality, mental health deterioration, child abuse and domestic violence, widening global inequality, food insecurity, lost educational opportunities, unhealthy lifestyle behaviours, social polarization, soaring debt, democratic backsliding and declining human rights. Young people, individuals and countries with lower socioeconomic status, women and those with pre-existing vulnerabilities were hit hardest. Societal harms should challenge the dominant mental model of the pandemic response: it is likely that many Covid policies caused more harm than benefit, although further research is needed to address knowledge gaps and explore policy trade-offs, especially at a country-level. Planning and response for future global health emergencies must integrate a wider range of expertise to account for and mitigate societal harms associated with government intervention.

Go here for a cliff-notes version of the study.

For more:

Category:

research, Viruses

Increased Occurrence of Treponema spp. and Double-Species Infections in Patients With Alzheimer’s Disease

https://www.sciencedirect.com/science/article/abs/pii/S0048969722042115?via%3Dihub

Increased occurrence of Treponema spp. and double-species infections in patients with Alzheimer’s disease

https://doi.org/10.1016/j.scitotenv.2022.157114Get rights and content

Highlights

  • Detection of five bacterial and five viral pathogens in serum and cerebrospinal fluid.
  • An increased frequency of Alzheimer’s disease patients positive for Treponema spp.
  • A significantly higher prevalence of cases with two and more simultaneous infections.
  • The studied pathogens were widespread equally in serum and cerebrospinal fluid.
  • Paralleled analysis of multiple sample specimens provides complementary information.

Abstract

Although the link between microbial infections and Alzheimer’s disease (AD) has been demonstrated in multiple studies, the involvement of pathogens in the development of AD remains unclear. Here, we investigated the frequency of the 10 most commonly cited viral (HSV-1, EBV, HHV-6, HHV-7, and CMV) and bacterial (Chlamydia pneumoniae, Helicobacter pylori, Borrelia burgdorferi, Porphyromonas gingivalis, and Treponema spp.) pathogens in serum, cerebrospinal fluid (CSF) and brain tissues of AD patients. We have used an in-house multiplex PCR kit for simultaneous detection of five bacterial and five viral pathogens in serum and CSF samples from 50 AD patients and 53 healthy controls (CTRL). We observed a significantly higher frequency rate of AD patients who tested positive for Treponema spp. compared to controls (AD: 62.2 %; CTRL: 30.3 %; p-value = 0.007). Furthermore, we confirmed a significantly higher occurrence of cases with two or more simultaneous infections in AD patients compared to controls (AD: 24 %; CTRL 7.5 %; p-value = 0.029). The studied pathogens were detected with comparable frequency in serum and CSF. In contrast, Borrelia burgdorferi, human herpesvirus 7, and human cytomegalovirus were not detected in any of the studied samples. This study provides further evidence of the association between microbial infections and AD and shows that paralleled analysis of multiple sample specimens provides complementary information and is advisable for future studies.

For more:

Category:

Activism, Alzheimer's, Lyme, Viruses